|
2023
|
Invention
|
Pharmaceutical composition for treating or preventing cancer. As a technology that can be used fo... |
|
|
Invention
|
Chimeric antigen receptor. The present invention addresses the problem of providing a novel chime... |
|
|
Invention
|
Therapeutic agent for kras mutant cancer. The purpose of the present invention is to addresses th... |
|
|
Invention
|
Method for isolating antigen molecule. The present invention addresses the problem of providing a... |
|
|
Invention
|
Sturgeon breeding method, sturgeon production method, and solid feed for sturgeon. [Problem] To p... |
|
|
Invention
|
Colorectal cancer biomarker and use thereof. The present invention provides a colorectal cancer b... |
|
|
Invention
|
Kit for detecting glycoprotein. Provided is a kit for detecting a glycoprotein contained in a sam... |
|
|
Invention
|
Multispecific nanoparticle. The present invention addresses the problem of providing a new acellu... |
|
2022
|
Invention
|
Chimeric cytokine receptor.
A technique for enhancing functions such as proliferation ability an... |
|
|
Invention
|
Chimeric cytokine receptor. To simultaneously improve therapeutic efficacy and reduce side effect... |
|
|
Invention
|
Usag-1 molecule-targeting neutralizing antibody for tooth regeneration treatment. Provided are: a... |
|
2021
|
Invention
|
Medicine containing usag-1-targeting rna molecule for tooth regeneration therapy.
Provided is a ... |
|
|
Invention
|
Medicine containing usag-1-targeting rna molecule for tooth regeneration therapy. Provided is a m... |
|
|
Invention
|
Method for inducing feminization of eel, method for culturing eel, eel-feminizing agent, and feed... |
|
2019
|
Invention
|
Patient position correction method. Provided is a patient position correction method with which i... |
|
2017
|
Invention
|
Carbon fiber reinforced plastics extruded material and method for manufacturing same. The present... |
|
|
Invention
|
Cell slide glass specimen production apparatus, cell slide glass specimen production method, and ... |
|
2016
|
Invention
|
Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and ... |
|
|
Invention
|
Method for determining presence/absence of development of malignant lymphoma or leukemia, and dru... |
|
|
Invention
|
Coating liquid, composition for coating liquid, and refractory article having coating layer. Prov... |
|
2014
|
Invention
|
Device for isolating periphery circulating tumor cells or rare cells, and method of isolating per... |
|
|
Invention
|
Device for isolating peripheral circulating tumor cells or rare cells, and method for isolating p... |
|
2012
|
Invention
|
Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovar... |
|
|
Invention
|
Method of classifying gene expression strength in lung cancer tissues.
The present invention pro... |
|
|
Invention
|
Epithelial ovarian cancer differentiation marker. The purpose of the present invention is to deve... |
|
2011
|
Invention
|
Cancer cell-specific cell-penetrating peptide and use thereof. Disclosed are: a cancer cell-speci... |
|
2010
|
Invention
|
Method of classifying gene expression strength in lung cancer tissues. The present invention prov... |
|
2009
|
Invention
|
Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same. A pep... |
|
2008
|
Invention
|
Method and composition for predicting the postsurgical recurrence in patient suffering from pulmo... |
|
|
Invention
|
Antibody reacting with n-acetylglucosamine-6-o-sulfotransferase product.
GlcNAcβ1-3Galβ1-4GlcNAc... |
|
|
Invention
|
Types of lymphoma and method for prognosis thereof.
A method for determining the prognosis of a ... |
|
2007
|
Invention
|
Composition for treating cancer using dref as molecular target. It is intended to provide a compo... |
|
|
Invention
|
Ameliorating agent for brain damage.
The present invention provides a pharmaceutical composition... |
|
|
Invention
|
Chondroitin sulfate degradation to ameliorate brain damage induced by hypoxia. The present invent... |
|
|
Invention
|
Ameliorating agent for brain damage. Disclosed is a pharmaceutical composition for the ameliorati... |
|
|
Invention
|
Novel composition for treating cancer. A medicinal composition for treating cancer which contains... |
|
|
Invention
|
Process for producing core/sheath conjugate elastomer fiber.
The present invention provides a pr... |
|
|
Invention
|
Process for producing core/sheath conjugate elastomer fiber. A process for producing a conjugate ... |
|
|
Invention
|
Biological marker for predicting postoperative prognosis of lung cancer patient and method theref... |
|
2006
|
Invention
|
Cytotoxic t-cell epitope peptide capable of specifically attacking cell infected with epstein-bar... |
|
|
Invention
|
Method for prediction of postoperative prognosis for patient with pulmonary adenocarcinoma, and c... |
|
|
Invention
|
Diagnostic method and prognostic method for disease type of diffuse large b-cell lymphoma. An obj... |
|
|
Invention
|
Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pha... |
|
|
Invention
|
Liposome composition for induction of immunity.
It is an object of the present invention to prov... |
|
|
Invention
|
Liposome composition for immune induction. It is an object of the present invention to provide a ... |
|
2005
|
Invention
|
Methods for diagnosis and prognosis of malignant lymphoma.
In order to more accurately analyze a... |
|
|
Invention
|
Drug delivery system using an immune response system.
The object of the present invention is to ... |
